STE analyst estimates
STERIS (STE) analyst ratings, the average price target and its range, and every firm's latest call.
STE analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jul 28, 2026 | UBS | Steris initiated with a Buy at UBS | $275.00 |
| May 21, 2026 | Piper Sandler | Piper Sandler: 'Is now the time to buy STERIS (STE)?' | $270.00 |
| May 13, 2026 | KeyBanc | Steris price target lowered to $269 from $291 at KeyBanc | $269.00 |
| Oct 24, 2024 | Piper Sandler | Piper Sandler Upgrades STERIS (STE) to Overweight | $260.00 |
| Sep 3, 2024 | KeyBanc | Steris price target raised to $265 from $255 at KeyBanc | $265.00 |
| May 10, 2024 | Piper Sandler | STERIS (STE) PT Raised to $225 at Piper Sandler | $225.00 |
| Apr 4, 2024 | Wolfe Research | STERIS (STE) PT Raised to $245 at Wolfe Research | $245.00 |
- 3 firms rate STE: 3 buy, 0 hold, 0 sell.
- The average price target is $271.33 from 3 analysts, from $269.00 to $275.00.
Updated 2026-11-02 23:10 UTC